Tag:
McKesson
Latest Headlines
Latest Headlines
Congress probes whether small wholesalers are gouging drug prices
Congress is investigating whether some small drug wholesalers are gaming the system by setting up their own pharmacies to get their hands on drugs in short supply.
McKesson, J&J eye GHX platform for e-pedigree
E-commerce service provider Global Healthcare Exchange (GHX) is looking for drug manufacturers, wholesalers and retailers willing to test the data exchange system it hopes will become the
Cardinal and McKesson positive, upbeat on financials
Drug distributors Cardinal Health ( $CAH ) and McKesson ( $MCK ) each reported positive financials for the last fiscal quarter and say they are upbeat about the future. Cardinal credits its generics
Teva walloped $163M in hepC ruling, doc 'unfit' for trial
The other shoe has dropped for Teva ( $TEVA ) and supply chain partners Baxter ( $BAX ) and McKesson ( $MCK ) in the case of a hepatitis C outbreak that followed reuse of jumbo-sized vials of propofol at a
Jury adds $162M to damages in Teva case
These are the kinds of big numbers a drugmaker doesn't want to see. The Nevada jury that delivered a $20 million verdict against Teva Pharmaceutical Industries ( $TEVA ) and its co-defendants last week
Teva, partners fined $20M in second propofol/Hep-C case
Generics-maker Teva ( $TEVA ), its partner Baxter ( $BAX ) and distributor McKesson ( $MCK ) have been ordered to pay $20 million to three Las Vegas colonoscopy patients who contracted hepatitis C
Jury levies $20M verdict against Teva in propofol case
Teva Pharmaceutical Industries ( $TEVA ) failed to persuade a Nevada jury its propofol drug wasn't responsible for a 2008 hepatitis C outbreak. The panel found Teva liable in the case, along with
McKesson VP reveals secret to meeting distribution challenges
The ballots have been cast and the winner is...Don Walker, senior VP for distribution operations at Big 3 wholesaler McKesson Pharmaceutical. He's been named one of DC Velocity's 15 Rainmakers for
McKesson goes all out on MS distribution center
Big 3 drug distributor McKesson says it's made the largest investment in its history: a $120 million distribution facility on a 67-acre site in the Olive Branch, MS. The 647,000 square-foot facility
Specialty drugs come to Big Pharma's rescue
Specialty drugs are in the news again this week. A Reuters report quotes Sanofi CEO Chris Viehbacher ( photo ) as saying the mass market for drugs "is really starting to disappear." That's very likely
